Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4280

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-4280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Venlafaxine Hydrochloride 75 mg extended-release capsules. The label indicates a quantity of 30 capsules and includes manufacturer information for RemedyRepack Inc. It also shows storage instructions and a barcode with NDC 70518-4280-00. The product is marked RX only.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A dot plot chart illustrating fold changes with 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of venlafaxine and its metabolite ODV across special populations. The chart compares hepatic impairment, renal impairment, CYP2D6 polymorphisms, age, and gender effects, showing changes relative to a reference value on the x-axis.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A scatter plot with error bars showing fold changes and 90% confidence intervals of pharmacokinetic (PK) parameters (Cmax, AUC) and ODV levels for venlafaxine hydrochloride when interacting with various drugs (Ethanol, Diazepam, Cimetidine, Ketoconazole in CYP2D6 EM's and PM's, Indinavir, Metoprolol, Imipramine, Lithium). The x-axis represents the change relative to the reference value, ranging from 0 to 3.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of various interacting drugs and their analytes relative to a reference value. Drugs include Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. The x-axis represents change relative to the reference value from 0 to 3.*
FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Venlafaxinestructure (Venlafaxinestructure)
Chemical structure of Venlafaxine Hydrochloride showing its molecular configuration, including the chiral center, hydroxyl group, methoxyphenyl ring, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.